Human Papillomavirus in Young People Epidemiological Research 4 (HYPER4)

Monash University

Status

Enrolling

Conditions

Anal Cancer

HPV

HPV Infection

Men

Human Papillomavirus Infection

Cancer

HPV 16 Infection

Study type

Observational

Funder types

Other

Identifiers

NCT05587738

15/22

Details and patient eligibility

About

Anal cancer is overrepresented among gay, bisexual and other men who have sex with men (MSM), particularly those living with HIV. Australia was the first country to introduce a publicly funded national HPV vaccination program in 2007. This program was expanded to include schoolboys aged 12-13 years in 2013; with a 2-year catch-up for boys aged up to 15 years.

The goal of the HYPER4 study is to determine the prevalence of anal, genital and oral HPV among 500 young gay and bisexual men aged 21-25 years who were eligible for the school-based gender-neutral quadrivalent vaccination program.

Participants will be required to complete a questionnaire and provide samples for HPV testing. No follow-up visits will be required.

Enrollment

500 estimated patients

Sex

Male

Ages

21 to 25 years old

Volunteers

No Healthy Volunteers

Inclusion criteria